Back
Kymera Therapeutics Stock Price Chart
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
77
KYMR
Kymera Therapeutics
Last Price:
$45.92
Seasonality Move:
30.84%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.09 | Sell |
| 20-day SMA: | 41.33 | Buy |
| 50-day SMA: | 34.42 | Buy |
| 200-day SMA: | 39.62 | Buy |
| 8-day EMA: | 46.1 | Sell |
| 20-day EMA: | 42.54 | Buy |
| 50-day EMA: | 37.49 | Buy |
| 200-day EMA: | 36.91 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.05 | Buy |
| Relative Strength Index (14 RSI): | 67.57 | Buy |
| Chaikin Money Flow: | 251231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.82 - 47.48) | Buy |
| Bollinger Bands (100): | (27.31 - 40.79) | Buy |
Kymera Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
-
Kymera Therapeutics share price is 45.87 while KYMR 8-day simple moving average is 47.09, which is a Sell signal.
-
The stock price of KYMR is 45.87 while Kymera Therapeutics 20-day SMA is 41.33, which makes it a Buy.
-
Kymera Therapeutics 50-day simple moving average is 34.42 while KYMR share price is 45.87, making it a Buy technically.
-
KYMR stock price is 45.87 and Kymera Therapeutics 200-day simple moving average is 39.62, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a BuyThe current Kymera Therapeutics [KYMR] share price is $45.87. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
3B
Price in USD:
45.87
Share Volume:
947.6K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
19.45
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?The Kymera Therapeutics stock price is 45.87 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
-
Kymera Therapeutics share price is 45.87 while KYMR 8-day exponential moving average is 46.10, which is a Sell signal.
-
The stock price of KYMR is 45.87 while Kymera Therapeutics 20-day EMA is 42.54, which makes it a Buy.
-
Kymera Therapeutics 50-day exponential moving average is 37.49 while KYMR share price is 45.87, making it a Buy technically.
-
KYMR stock price is 45.87 and Kymera Therapeutics 200-day simple moving average is 36.91, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 4.05, suggesting Kymera Therapeutics is a Buy
-
Kymera Therapeutics Relative Strength Index (RSI) is 67.57, which suggest Kymera Therapeutics is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics is (30.82 - 47.48), which suggest Kymera Therapeutics is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics is (27.31 - 40.79), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.